文献速递腹部泌尿生殖CT

透明细胞肾细胞癌与其他肾脏肿瘤的表征:物质特异性碘与脂肪双能CT成像评估

Characterization of clear cell renal cell carcinoma and other renal tumors: evaluation of dual-energy CT using material-specific iodine and fat imaging.
PubMed 文献 · Eur Radiol · 2019-12-19

该研究纳入2016至2018年经组织学证实的25例透明细胞肾细胞癌、11例乳头状肾细胞癌和6例其他肾脏肿瘤,评估快速kVp切换双能CT物质特异性碘与脂肪图像。透明细胞肾细胞癌碘浓度显著高于乳头状肾细胞癌,但与其他肿瘤有重叠;碘浓度≤2.5 mg/mL鉴别乳头状肾细胞癌高度准确;物质特异性脂肪图像上微观脂肪的存在对透明细胞肾细胞癌具有特异性。

要点

  • 透明细胞肾细胞癌碘浓度(6.14±1.79 mg/mL)显著高于乳头状肾细胞癌(1.40±0.54 mg/mL,p<0.001)。
  • 物质特异性脂肪图像上微观脂肪的存在对透明细胞肾细胞癌具有特异性,有助于与其他富血供肿瘤鉴别。

核心结论

  • 碘浓度值鉴别透明细胞肾细胞癌与乳头状肾细胞癌高度准确,但与其他肿瘤的数值存在重叠。
  • 脂肪特异性图像可能改善透明细胞肾细胞癌与其他富血供肿瘤的鉴别。

研究设计与样本

  • 经IRB批准,纳入2016至2018年经组织学证实的实性肾脏肿块,均行快速kVp切换双能CT。
  • 样本包括25例透明细胞肾细胞癌(7例低级别 vs 18例高级别)、11例乳头状肾细胞癌和6例其他肿瘤(2例透明细胞乳头状肾细胞癌、2例嫌色细胞肾细胞癌、1例嗜酸细胞瘤、1例肾血管平滑肌脂肪瘤)。
  • 由一名盲法放射科医生在物质特异性碘-水和脂肪-水基对图像上测量碘浓度与脂肪浓度,组间比较采用单因素分析,诊断准确性通过ROC计算。

关键影像表现/征象

  • 透明细胞肾细胞癌碘浓度为6.14±1.79 mg/mL,高于乳头状肾细胞癌的1.40±0.54 mg/mL(p<0.001),但与其他肿瘤的5.0±2.2 mg/mL相比差异无统计学意义(p=0.370)。
  • 瘤内脂肪见于36.0%(9/25)的透明细胞肾细胞癌(309.6±234.3 mg/mL [71.1-762.3 ng/mL])、9.1%(1/11)的乳头状肾细胞癌(97.11 mg/mL),其他肿瘤中未见(p=0.036)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: This study aimed to assess material-specific iodine and fat images for diagnosis of clear cell renal cell carcinoma (cc-RCC) compared to papillary RCC (p-RCC) and other renal masses.

MATERIALS AND METHODS: With IRB approval, we identified histologically confirmed solid renal masses that underwent rapid-kVp-switch DECT between 2016 and 2018: 25 cc-RCC (7 low grade versus 18 high grade), 11 p-RCC, and 6 other tumors (2 clear cell papillary RCC, 2 chromophobe RCC, 1 oncocytoma, 1 renal angiomyomatous tumor). A blinded radiologist measured iodine and fat concentration on material-specific iodine-water and fat-water basis pair images. Comparisons were performed between groups using univariate analysis and diagnostic accuracy calculated by ROC.

RESULTS: Iodine concentration was higher in cc-RCC (6.14 ± 1.79 mg/mL) compared to p-RCC (1.40 ± 0.54 mg/mL, p < 0.001), but not compared to other tumors (5.0 ± 2.2 mg/mL, p = 0.370). Intratumoral fat was seen in 36.0% (9/25) cc-RCC (309.6 ± 234.3 mg/mL [71.1-762.3 ng/mL]), 9.1% (1/11) papillary RCC (97.11 mg/mL), and no other tumors (p = 0.036). Iodine concentration ≥ 3.99 mg/mL achieved AUC and sensitivity/specificity of 0.88 (CI 0.76-1.00) and 92.31%/82.40% to diagnose cc-RCC. To diagnose p-RCC, iodine concentration ≤ 2.5 mg/mL achieved AUC and sensitivity/specificity of 0.99 (0.98-1.00) and 100%/100%. The presence of intratumoral fat had AUC 0.64 (CI 0.53-0.75) and sensitivity/specificity of 34.6%/93.8% to diagnose cc-RCC. A logistic regression model combining iodine concentration and presence of fat increased AUC to 0.91 (CI 0.81-1.0) with sensitivity/specificity of 80.8%/93.8% to diagnose cc-RCC.

CONCLUSION: Iodine concentration values are highly accurate to differentiate clear cell RCC from papillary RCC; however, they overlap with other tumors. Fat-specific images may improve differentiation of clear cell RCC from other avidly enhancing tumors.

KEY POINTS: • Clear cell renal cell carcinoma (RCC) has significantly higher iodine concentration than papillary RCC, but there is an overlap in values comparing clear cell RCC to other renal tumors. • Iodine concentration ≤ 2.5 mg/mL is highly accurate to differentiate papillary RCC from clear cell RCC and other renal tumors. • The presence of microscopic fat on material-specific fat images was specific for clear cell RCC, helping to differentiate clear cell RCC from other avidly enhancing renal tumors.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Udare A, Walker D, Krishna S, et al. Characterization of clear cell renal cell carcinoma and other renal tumors: evaluation of dual-energy CT using material-specific iodine and fat imaging. Eur Radiol. 2019. PMID: 31858204. doi:10.1007/s00330-019-06590-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。